Skip to content

Application of narrative nursing intervention program for patients with autoimmune skin diseases

Application of narrative nursing intervention program for patients with autoimmune skin diseases

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121847
Enrollment
Unknown
Registered
2026-04-03
Start date
2026-04-05
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The clinical and pathological diagnosis of autoimmune skin diseases ( lupus erythematosus, scleroderma, dermatomyositis, pemphigus, bullous pemphigoid, herpetic dermatitis, bullous epidermolysis bullosa, various types of psoriasis, allergic vasculitis, white atrophy, allergic purpura, urticaria vasculitis, vitiligo, alopecia areata and alopecia totalis, etc. )

Interventions

interventional group:Typed narrative nursing preset intervention program
control group:Dermatology routine nursing and health guidance.

Sponsors

Peking Union Medical College Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 18 years old; 2.The clinical and pathological diagnosis of autoimmune skin diseases ( lupus erythematosus, scleroderma, dermatomyositis, pemphigus, bullous pemphigoid, herpetic dermatitis, bullous epidermolysis bullosa, various types of psoriasis, allergic vasculitis, white atrophy, allergic purpura, urticaria vasculitis, vitiligo, alopecia areata and alopecia totalis, etc. ); 3.Psychological distress : the total score of hospital anxiety and depression scale at admission = 8 points; 4.Informed consent, voluntary participation in this study;

Exclusion criteria

Exclusion criteria: 1.Patients with severe mental illness unable to cooperate; 2.Patients with severe infection and unstable vital signs who are not suitable to participate in the study. 3.Patients who are participating in other clinical studies related to psychological interventions;

Design outcomes

Primary

MeasureTime frame
Hospital Anxiety and Depression Scale;

Secondary

MeasureTime frame
Athens Insomnia Scale;Dermatology Life Quality Index;General Information Questionnaire;Brief Illness Perception Questionnaire;Morisky Medication Adherence Scale-8;Medical Coping Modes Questionnaire;

Countries

China

Contacts

Public ContactDongxiaolan

Peking Union Medical College Hospital

22286444@qq.com+86 10 6915 6395

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026